Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis is a research paper published in Trends in Pharmacological Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart Lung and Blood Institute
Grant: R00 HL150234
National Institutes of Health
FWCI
9.92
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords